Skip to main content

APLICACION DE ESTRATEGIAS POST-GWAS EN LA IDENTIFICACION DEL COMPONENTE GENETICO DE LA ESCLERODERMIA

SAF2012-34435

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Nacional de Proyectos de Investigación Fundamental
Subprogram Subprograma de Proyectos de Investigación Fundamental no Orientada
Call Proyectos I+D
Call year 2012
State Plan 2008-2011 Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica
Management unit Secretaría de Estado de Investigación, Desarrollo e Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility

  • López-Isac, Elena|||0000-0001-8806-5148
  • Bossini-Castillo, Lara|||0000-0002-5471-5824
  • Simeón-Aznar, Carmen Pilar|||0000-0003-3390-9029
  • Egurbide, María Victoria
  • Alegre-Sancho, Juan José|||0000-0003-1641-0875
  • Callejas Rubio, Jose Luis|||0000-0002-1653-0087
  • Roman-Ivorra, José Andrés
  • Freire, Mayka
  • Beretta, Lorenzo|||0000-0002-6529-6258
  • Santaniello, Alessandro
  • Airò, Paolo
  • Lunardi, Claudio|||0000-0001-6446-2990
  • Hunzelmann, Nicolas
  • Riemekasten, Gabriela
  • Witte, Torsten
  • Kreuter, Alexander|||0000-0003-2275-499X
  • Distler, Jörg H.W.
  • Schuerwegh, Annemie J.
  • Vonk, Madelon C.
  • Voskuyl, A.E.|||0000-0002-9699-1827
  • Shiels, Paul G.
  • van Laar, Jacob M.
  • Fonseca, Carmen
  • Denton, Christopher P.
  • Herrick, Ariane|||0000-0003-4941-7926
  • Worthington, Jane
  • Assassi, Shervin|||0000-0002-8059-9978
  • Koeleman, Bobby P.
  • Mayes, Maureen D.|||0000-0001-5070-2535
  • Radstake, Timothy R.D.J.
  • Martín, Javier|||0000-0002-2202-0622
  • Ortego-Centeno, Norberto|||0000-0003-2325-0937
  • Ríos, Raquel
  • Navarrete Navarrete, Nuria
  • Portales, Rosa García
  • Camps, Mª Teresa
  • Fernández-Nebro, Antonio|||0000-0002-2962-9844
  • González-Escribano, María Francisca
  • Sánchez-Román, Julio
  • García-Hernández, Francisco José
  • Castillo, María Jesús
  • Aguirre, M. Ángeles
  • Gómez-Gracia, Inmaculada
  • Carreira, Patricia E.|||0000-0001-8279-3806
  • Fernández-Gutiérrez, B.|||0000-0002-6126-8786
  • Rodriguez-Rodriguez, Luis|||0000-0002-2869-7861
  • Vicente, Eva
  • Andréu, José Luis|||0000-0002-6002-1239
  • de Castro, Mónica Fernández
  • García de la Peña, Paloma
  • López Longo, Francisco Javier
  • Martínez, Lina
  • Fonollosa Pla, Vicent
  • Espinosa, Gerard|||0000-0003-1336-0163
  • Castellvi, Ivan|||0000-0002-5410-5807
  • Tolosa, Carlos
  • Pros, Ana|||0000-0003-0266-0531
  • Carballeira, Monica Rodriguez
  • Narváez, Javier|||0000-0002-1614-8064
  • Rubio Rivas, Manuel|||0000-0002-9548-1374
  • Santamarí, V.O.
  • Gonzalez-Gay, MA.|||0000-0002-7924-7406
  • Díaz, Bernardino
  • Trapiella, Luis
  • Sousa, Adrián
  • Mateo, Patricia Fanlo
  • Sáez-Comet, Luis|||0000-0002-9868-6498
  • Díaz, Federico
  • Hernández, Vanessa
  • Beltrán, E.
  • Blanco-García, F.J.|||0000-0001-9821-7635
  • Oreiro, Natividad
Introduction: A recent genome-wide association study (GWAS) comprising a French cohort of systemic sclerosis (SSc) reported several non-HLA single-nucleotide polymorphisms (SNPs) showing a nominal association in the discovery phase. We aimed to identify previously overlooked susceptibility variants by using a follow-up strategy.Methods: Sixty-six non-HLA SNPs showing a P value <10 in the discovery phase of the French SSc GWAS were analyzed in the first step of this study, performing a meta-analysis that combined data from the two published SSc GWASs. A total of 2,921 SSc patients and 6,963 healthy controls were included in this first phase. Two SNPs, PPARG rs310746 and CHRNA9 rs6832151, were selected for genotyping in the replication cohort (1,068 SSc patients and 6,762 healthy controls) based on the results of the first step. Genotyping was performed by using TaqMan SNP genotyping assays.Results: We observed nominal associations for both PPARG rs310746 (P = 1.90 × 10, OR, 1.28) and CHRNA9 rs6832151 (P = 4.30 × 10, OR, 1.17) genetic variants with SSc in the first step of our study. In the replication phase, we observed a trend of association for PPARG rs310746 (P value = 0.066; OR, 1.17). The combined overall Mantel-Haenszel meta-analysis of all the cohorts included in the present study revealed that PPARG rs310746 remained associated with SSc with a nominal non-genome-wide significant P value (P = 5.00 × 10; OR, 1.25). No evidence of association was observed for CHRNA9 rs6832151 either in the replication phase or in the overall pooled analysis.Conclusion: Our results suggest a role of PPARG gene in the development of SSc. © 2014 López-Isac et al.; licensee BioMed Central Ltd.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies

  • López-Isac, Elena
  • Martin, J. E.
  • Assassi, Shervin
  • Simeón, Carmen P.
  • Carreira, Patricia E.
  • Ortego-Centeno, Norberto
  • Freire, María del Carmen
  • Beltrán, E.
  • Narváez, Javier
  • Alegre-Sancho, Juan-José
  • Fernández-Gutiérrez, Benjamín
  • Balsa, Alejandro
  • Ortiz, Ana María
  • González-Gay, Miguel A.
  • Beretta, Lorenzo
  • Santaniello, Alessandro
  • Bellocchi, Chiara
  • Lunardi, C.
  • Moroncini, Gianluca
  • Gabrielli, Armando
  • Witte, Torsten
  • Hunzelmann, Nicolas
  • Distler, Jörg H. W.
  • Riekemasten, Gabriella
  • van der Helm-Van Mil, Annette H. M.
  • Vries-Bouwstra, Jeska K. de
  • Magro-Checa, Cesar
  • Voskuyl, Alexandre E.
  • Vonk, Madelon C.
  • Molberg, Oyvind
  • Merriman, Tony R.
  • Hesselstrand, Roger
  • Nordin, A.
  • Padyukov, Leonid
  • Herrick, A.
  • Eyre, Steve
  • Koeleman, B. P.
  • Denton, Christopher
  • Fonseca, Carmen
  • Radstake, T. R.
  • Worthington, J.
  • Mayes, Maureen D.
  • Martín, J.
Autoría conjunta: Spanish Scleroderma Grp, Objective. Systemic sclerosis (SSc) and rheumatoid arthritis (RA) are autoimmune diseases that have similar clinical and immunologic characteristics. To date, several shared SSc-RA genetic loci have been identified independently. The aim of the current study was to systematically search for new common SSc-RA loci through an interdisease meta-genome-wide association (meta-GWAS) strategy. Methods. The study was designed as a meta-analysis combining GWAS data sets of patients with SSc and patients with RA, using a strategy that allowed identification of loci with both same-direction and opposite-direction allelic effects. The top single-nucleotide polymorphisms were followed up in independent SSc and RA case-control cohorts. This allowed an increase in the sample size to a total of 8,830 patients with SSc, 16,870 patients with RA, and 43,393 healthy controls. Results. This cross-disease meta-analysis of the GWAS data sets identified several loci with nominal association signals (P<5 x 10(-6)) that also showed evidence of association in the disease-specific GWAS scans. These loci included several genomic regions not previously reported as shared loci, as well as several risk factors that were previously found to be associated with both diseases. Follow-up analyses of the putatively new SSc-RA loci identified IRF4 as a shared risk factor for these 2 diseases (P-combined=3.29 x 10(-12)). Analysis of the biologic relevance of the known SSc-RA shared loci identified the type I interferon and interleukin-12 signaling pathways as the main common etiologic factors. Conclusion. This study identified a novel shared locus, IRF4, for the risk of SSc and RA, and highlighted the usefulness of a cross-disease GWAS meta-analysis strategy in the identification of common risk loci., Supported by a grant from the Ministerio de Educacion, Cultura y Deporte through the program FPU (to Dr. Lopez-Isac), grant 115565 from the EU/EFPIA Innovative Medicines Initiative Joint Undertaking PRECISESADS (ref. no. 115565) and BIO-1395 from the Junta de Andalucia, grant PI-0590-2010 from the Consejeria de Salud y Bienestar Social, Junta de Andalucia, Spain (to Dr. Ortego-Centeno), a VIDI laureate from the Dutch Association of Research and Dutch Arthritis Foundation (to Dr. Radstake), and grant SAF2012-34435 from the Spanish Ministry of Economy and Competitiveness (to Dr. J. Martin). Dr. Assassi's work was supported by grants KL2-RR-024149-04 and K23-AR-061436 from the NIH, grant 3-UL1-RR-024148 from the NIH National Center for Research Resources, and grant U01-1U01AI09090 from the NIH National Institute of Allergy and Infectious Diseases. Dr. Mayes' work was supported by grant P50-AR-054144 from the NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Centers of Research Translation, grant N01-AR-0-2251 from the NIAMS SSc Family Registry and DNA Repository, grant PR-1206877 from the Department of Defense, and grant R01-AR-055258 from the NIAMS., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy

  • Carmona, F. David|||0000-0002-1427-7639
  • Coit, Patrick
  • Saruhan-Direskeneli, Güher
  • Hernández Rodríguez, José|||0000-0002-2357-2015
  • Cid, María Cinta|||0000-0002-4730-0938
  • Solans, Roser|||0000-0002-0058-1293
  • Castañeda, Santos|||0000-0002-7748-853X
  • Vaglio, Augusto
  • Direskeneli, Haner
  • Merkel, Peter A.|||0000-0001-9284-7345
  • Boiardi, Luigi
  • Salvarani, Carlo|||0000-0001-5426-5133
  • Gonzalez-Gay, MA.|||0000-0002-7924-7406
  • Martín, Javier|||0000-0002-2202-0622
  • Sawalha, Amr H.
Giant cell arteritis (GCA) and Takayasu's arteritis (TAK) are major forms of large-vessel vasculitis (LVV) that share clinical features. To evaluate their genetic similarities, we analysed Immunochip genotyping data from 1,434 LVV patients and 3,814 unaffected controls. Genetic pleiotropy was also estimated. The HLA region harboured the main disease-specific associations. GCA was mostly associated with class II genes (HLA-DRB1 / HLA-DQA1) whereas TAK was mostly associated with class I genes (HLA-B/MICA). Both the statistical significance and effect size of the HLA signals were considerably reduced in the cross-disease meta-analysis in comparison with the analysis of GCA and TAK separately. Consequently, no significant genetic correlation between these two diseases was observed when HLA variants were tested. Outside the HLA region, only one polymorphism located nearby the IL12B gene surpassed the study-wide significance threshold in the meta-analysis of the discovery datasets (rs755374, P = 7.54E-07; OR = 1.19, OR = 1.50). This marker was confirmed as novel GCA risk factor using four additional cohorts (P = 5.52E-04, OR = 1.16). Taken together, our results provide evidence of strong genetic differences between GCA and TAK in the HLA. Outside this region, common susceptibility factors were suggested, especially within the IL12B locus.